List of Figures
Figure 1: Global Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Figure 2: Global Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 3: Estimated Incidences of Global Cancer Cases, By percent, 2012
Figure 4: Estimated Incidences of Global Cancer Cases, By Percent, By Region, 2012
Figure 5: Global Antibody Drug Conjugates Market Size and Share, By Drug, 2016
Figure 6: Key Drivers
Figure 7: Global Antibody Drug Conjugates Market Size and Share, By Drug, 2022
Figure 8: Key Drivers
Figure 9: Global Adcetris Market Size, By Value, 2012-2016 (USD Million)
Figure 10: Global Adcetris Market Size, By Value, 2017E-2022F (USD Million)
Figure 11: Global Kadcyla Market Size, By Value, 2013-2016 (USD Million)
Figure 12: Global Kadcyla Market Size, By Value, 2017E-2022F (USD Million)
Figure 13: Global Antibody Drug Conjugates Market Size and Share, By Region, 2016
Figure 14: Key Drivers
Figure 15: Global Antibody Drug Conjugates Market Size and Share, By Segments, 2022
Figure 16: Key Drivers
Figure 17: North America Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Figure 18: North America Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 19: Population aged 65 & above, 2011-2015 (% of total)
Figure 20: North America Adcetris Market Size, By Value, 2012-2016 (USD Million)
Figure 21: North America Adcetris Market Size, By Value, 2017E-2022F (USD Million)
Figure 22: North America Kadcyla Market Size, By Value, 2013-2016 (USD Million)
Figure 23: North America Kadcyla Market Size, By Value, 2017E-2022F (USD Million)
Figure 24: U.S. Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Figure 25: U.S. Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 26: Top Cancer in US per 100,000 population, 2013
Figure 27: Canada Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Figure 28: Canada Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 29: Percent Distribution of New Cancer Cases in Males, in Canada, 2016
Figure 30: Percent Distribution of New Cancer Cases in Females, in Canada, 2016
Figure 31: Europe Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Figure 32: Europe Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 33: European Country Population Aged 65 and Above, 2011-2015 (% of Total)
Figure 34: Cancer Frequency in Europe, By Country, Per 100000 Population, 2012
Figure 35: Europe Adcetris Market Size, By Value, 2012-2016 (USD Million)
Figure 36: Europe Adcetris Market Size, By Value, 2017E-2022F (USD Million)
Figure 37: Europe Kadcyla Market Size, By Value, 2013-2016 (USD Million)
Figure 38: Europe Kadcyla Market Size, By Value, 2017E-2022F (USD Million)
Figure 39: Germany Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Figure 40: Germany Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 41: Estimated Incidences of Cancer in Germany, 2012
Figure 42: Estimated Mortality of Cancer in Germany, 2012
Figure 43: France Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Figure 44: France Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 45: Estimated Incidences of Cancer in France, 2012
Figure 46: Estimated Mortality of Cancer in France, 2012
Figure 47: U.K. Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Figure 48: U.K. Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 49: Estimated Incidences of Cancer in U.K., 2012
Figure 50: Estimated Mortality of Cancer in U.K., 2012
Figure 51: Rest of Europe Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Figure 52: Rest of Europe Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 53: Asia Pacific Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Figure 54: Asia Pacific Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 55: Estimated Cases of Cancer in Asia Pacific, By Country, 2012
Figure 56: Asia Pacific Adcetris Market Size, By Value, 2012-2016 (USD Million)
Figure 57: Asia Pacific Adcetris Market Size, By Value, 2017E-2022F (USD Million)
Figure 58: Asia Pacific Kadcyla Market Size, By Value, 2013-2016 (USD Million)
Figure 59: Asia Pacific Kadcyla Market Size, By Value, 2017E-2022F (USD Million)
Figure 60: Japan Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Figure 61: Japan Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 62: Japan Population Aged 65 and Above, 2011-2015 (% of Total)
Figure 63: China Antibody Drug Conjugates Market Size, By Value, 2015-2016 (USD Million)
Figure 64: China Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 65: China Population Aged 65 and Above, 2011-2015 (% of Total)
Figure 66: Singapore Antibody Drug Conjugates Market Size, By Value, 2013-2016 (USD Million)
Figure 67: Singapore Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 68: India Antibody Drug Conjugates Market Size, By Value, 2015-2016 (USD Million)
Figure 69: India Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 70: Rest of Asia Pacific Antibody Drug Conjugates Market Size, By Value, 2013-2016 (USD Million)
Figure 71: Rest of Asia Pacific Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 72: Rest of World Antibody Drug Conjugates Market Size, By Value, 2013-2016 (USD Million)
Figure 73: Rest of World Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 74: Population Aged 65 and Above, By Country 2011-2015 (% of Total)
Figure 75: Rest of World Adcetris Market Size, By Value, 2013-2016 (USD Million)
Figure 76: Rest of World Adcetris Market Size, By Value, 2017E-2022F (USD Million)
Figure 77: Rest of World Kadcyla Market Size, By Value, 2013-2016 (USD Million)
Figure 78: Rest of World Kadcyla Market Size, By Value, 2017E-2022F (USD Million)
Figure 79: Brazil Antibody Drug Conjugates Market Size, By Value, 2014-2016 (USD Million)
Figure 80: Brazil Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 81: South Africa Antibody Drug Conjugates Market Size, By Value, 2015-2016 (USD Million)
Figure 82: South Africa Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 83: Others Antibody Drug Conjugates Market Size, By Value, 2013-2016 (USD Million)
Figure 84: Others Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Figure 85: F. Hoffmann-La Roche Ltd Segmental Break Up
Figure 86: F. Hoffmann-La Roche Ltd Geographical Break Up
Figure 87: Takeda Segmental Break Up
Figure 88: Takeda Geographical Break Up
Figure 89: Pfizer Segmental Break Up
Figure 90: Pfizer Geographical Break Up
Figure 91: Sanofi Segmental Break Up
Figure 92: Sanofi Geographical Break Up
Figure 93: AbbVie Segmental Break Up
Figure 94: AbbVie Geographical Break Up
List of Tables
Table A: On-going Clinical Trials of Adcetris
Table B: ADC Pipeline Analysis (By Drug, Developer, Phase, Indication, Status)
Table C: ADC Pipeline Analysis (By Cytotoxic Payload, Linker, Target)